Good Therapeutics

Seattle

Good Therapeutics is a biopharmaceutical organization involved in drug development, with notable activities related to acquiring and advancing therapeutic drug programs.

Facts

HQ
Seattle
Sectors
Biotechnology, Biopharmaceuticals, Immuno-oncology, Drug development
Stage
Series A
Members see funding amounts.
.

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Good Therapeutics

See all 5

Bonum Therapeutics Moves to New Seattle Offices, Plans Team Expansion in Cancer Immunotherapy Push

Seattle biotech startup Bonum Therapeutics is relocating to a new office at 1150 Eastlake Ave E and plans to double its 31-person team as it pursues developing safer immunotherapy cancer drugs. Founded by CEO John Mulligan after a $250 million acquisition of his previous company Good Therapeutics by Roche, Bonum recently raised $93 million to fund its expansion.

Online

Questions about Good Therapeutics

What is Good Therapeutics?

Seattle

Who invested in Good Therapeutics, and how much has it raised?

Members of Seattle Flow see Good Therapeutics' funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Good Therapeutics based?

Good Therapeutics is headquartered in Seattle.